NCT01133951View on ClinicalTrials.gov

Helicobacter Pylori Eradication to Prevent Gastric Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

3,000

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

January 31, 2012

Study Completion Date

May 31, 2032

Conditions
Helicobacter InfectionsStomach Neoplasms
Interventions
DRUG

OAC triple therapy

Omeprazole, 20mg, amoxicillin, 1000mg, and clarithromycin, 500mg, all twice a day for 2 weeks.

DRUG

Placebo

Omeprazole placebo, amoxicillin placebo, and clarithromycin placebo, all twice a day for 2 weeks.

Trial Locations (1)

212200

Zhao-Lai Hua M.D., Yangzhong

All Listed Sponsors
lead

Jie-Jun Wang

OTHER